Keywords: آنتی بادی اختصاصی اهداکننده; cardiovascular progenitor cells; embryonic stem cells; heart failure; tissue engineering; CT; computed tomography; DSA; donor-specific antibody; EF; ejection fraction; ESC; embryonic stem cell; hESC; human embryonic stem cell; HLA; human leukocyte antigen
مقالات ISI آنتی بادی اختصاصی اهداکننده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی اختصاصی اهداکننده; DSA; donor-specific antibody; HCV; hepatitis C virus; HLA; human leukocyte antigen; IL-6; interleukin 6; ISDT; immunosuppressive drug treatment; LT; liver transplant(ation); NK; natural killer; Non-TOL; non-tolerant; PBMC; peripheral blood mononuclear cel
Keywords: آنتی بادی اختصاصی اهداکننده; ABOi; ABO antibody incompatible; AIT; antibody incompatible transplantation; AMR; antibody-mediated rejection; DSA; donor-specific antibody; EC; endothelial cell; LDH; lactate dehydrogenase; HLAi; human leukocyte antigen-incompatible; HUS; hemolytic ure
Keywords: آنتی بادی اختصاصی اهداکننده; Allograft tolerance; Chimerism; Hematopoietic stem cell transplantation; Donor bone marrow transplantation; Kidney transplantation; NHPs; non-human primates; MHC; major histocompatibility complex; mAb; monoclonal antibody; TBI; total body irradiation; TI;
Keywords: آنتی بادی اختصاصی اهداکننده; AMR; antibody-mediated rejection; BOS; Bronchiolitis obliterans syndrome; CDC; complement-dependent cytotoxicity; CLAD; chronic lung allograft dysfunction; DSA; donor-specific antibody; HLA; human leukocyte antigen; ISHLT; International Society for Heart
Keywords: آنتی بادی اختصاصی اهداکننده; AMR; antibody-mediated rejection; DSA; donor-specific antibody; HEL; high expression loci; IVIG; intravenous immunoglobulin; LEL; low expression loci; MFI; mean fluorescent intensity; NR; nonresponders; R; responders; SAB; single antigen bead Luminex® as
Keywords: آنتی بادی اختصاصی اهداکننده; Orthotopic liver transplant; Antibody-mediated rejection; Donor-specific antibody; Anastomotic stricture; Biliary complication; Graft fibrosis
Keywords: آنتی بادی اختصاصی اهداکننده; ANZDATA; Australia and New Zealand Dialysis and Transplant Registry; BPAR; biopsy-proven acute rejection; CI; confidence interval; CNI; calcineurin inhibitor; CsA; cyclosporine; DSA; donor-specific antibody; HR; hazard ratio; IL-2R; interleukin 2 receptor
Keywords: آنتی بادی اختصاصی اهداکننده; Abs; antibodies; ATG; antithymocyte globulin; BSX; basiliximab; DSA; donor-specific antibody; DTT; dithiothreitol; ECZ; eculizumab; FC; flow cytometry; HLA; human leukocyte antigen; IVIg; intravenous immunoglobulin; LCT; lymphocytotoxicity; MoAbs; monoclo
Keywords: آنتی بادی اختصاصی اهداکننده; Cardiac transplantation; Endomyocardial biopsy; Donor-specific antibody; Antibody-mediated rejection;
Keywords: آنتی بادی اختصاصی اهداکننده; Plasma cells; Donor-specific antibody; Eosinophils; Solid organ transplantation; Desensitization
Heightened expression of HLA-DQB1 and HLA-DQB2 in pre-implantation biopsies predicts poor late kidney graft function
Keywords: آنتی بادی اختصاصی اهداکننده; Ct; cycle threshold; DSA; donor-specific antibody; eGFR; estimated glomerular filtration rate; HLA; human leukocyte antigen; nEU; normalized expression units; NPV; negative predictive value; PCR; polymerase chain reaction; PIB; pre-implantation biopsy; PP
De novo immune complex deposition in kidney allografts: a series of 32 patients
Keywords: آنتی بادی اختصاصی اهداکننده; ACR; acute cellular rejection; ABMR; antibody-mediated rejection; CMV; cytomegalovirus; DSA; donor-specific antibody; EM; electron microscopy; GN; glomerulonephritis; HCV; hepatitis C virus; IF; immunofluorescence; Ig; immunoglobulin; LM; light microscopy
Pre-transplant AT1R antibodies correlate with early allograft rejection
Keywords: آنتی بادی اختصاصی اهداکننده; Ab; antibody; Abs; antibodies; ABMR; antibody-mediated rejection; AR; acute rejection; AT1R; angiotensin II type 1 receptor; AT1R-Abs; antibodies against the angiotensin II type 1 receptor; dnDSA; de novo donor-specific antibody; DSA; donor-specific antib
Tubuloreticular inclusions in peritubular capillaries of renal allografts
Keywords: آنتی بادی اختصاصی اهداکننده; ACR; acute T cell-mediated rejection; AMR; antibody-mediated rejection; DSA; donor-specific antibody; HIV; human immunodeficiency virus; TRI; tubuloreticular inclusion; Tubuloreticular inclusion; Transplant; Peritubular capillary;
Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome
Keywords: آنتی بادی اختصاصی اهداکننده; AT1R; angiotensin II type-1 receptor; HLA; human leukocyte antigen; AMR; antibody-mediated rejection; CR; cellular rejection; BCR; borderline cellular rejection; AECAs; anti-endothelial cell antibodies; SOC; standard of care; DSA; donor-specific antibody;
Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition
Keywords: آنتی بادی اختصاصی اهداکننده; ABO-I; ABO-incompatible kidney transplantation; CAMR; chronic antibody mediated rejection; CDC; complement-dependent cytotoxicity; CIITA; class II transactivator; DSA; donor-specific antibody; HLA-I; HLA-incompatible kidney transplantation; Kidney transpl
Understanding solid-phase HLA antibody assays and the value of MFI
Keywords: آنتی بادی اختصاصی اهداکننده; MFI; mean fluorescence intensity; HLA; human leukocyte antigen; SAB; single antigen bead; DSA; donor-specific antibody; AMR; antibody mediated rejection; cPRA; calculated PRA; EDTA; Ethylenediaminetetraacetic acid; DTT; Dithiothreitol; PE; phycoerythrin;
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Keywords: آنتی بادی اختصاصی اهداکننده; AECA; anti-endothelial cell antibody; DSA; donor-specific antibody; ABMR; antibody-mediated rejection; Ab; antibody; Anti-endothelial cell antibody; Humoral rejection; Transplantation; Endothelial injury;
Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization
Keywords: آنتی بادی اختصاصی اهداکننده; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; DSA; donor-specific antibody; MFI; mean fluorescence intensity; SG; skin graft; Tfh; follicular T helper; B cell; CTLA4Ig; Donor specific antibody; HLA-sensitization; Mouse; Plasma cell;
A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy
Keywords: آنتی بادی اختصاصی اهداکننده; AMR; antibody-mediated rejection; AR; acute rejection; CKD; chronic kidney disease; CR; chronic rejection; DSA; donor specific antibodies; IF/TA; interstitial fibrosis/tubular atrophy; KIM-1; kidney injury molecule 1; MCP-1; macrophage chemotactic protein
Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; Antibody-mediated rejection; Donor-specific antibody; Graft survival; Kidney transplantation; Single-antigen bead assay
Orthostatic hypotension of unknown cause: Unanticipated association with elevated circulating N-terminal brain natriuretic peptide (NT-proBNP)
Keywords: آنتی بادی اختصاصی اهداکننده; ANP; atrial natriuretic peptide; BNP; brain natriuretic peptide; BP; blood pressure; CT-proAVP; C-terminal pro-arginine vasopressin; CT-proET-1; C-terminal endothelin-1 precursor fragment; DSA; donor-specific antibody; ESRD; end-stage renal disease; HF; h
Impact des anticorps anti-HLA sur le devenir de l’allogreffe de cellules souches hématopoïétiques : un rapport par la SFGM-TC
Keywords: آنتی بادی اختصاصی اهداکننده; Anticorps anti-HLA; Allogreffe de cellules souches hématopoïétiques; Anticorps spécifique anti-HLA du donneurAnti-HLA antibodies; Allogeneic stem cell transplantation; Donor-specific antibody
Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy
Keywords: آنتی بادی اختصاصی اهداکننده; ABO-i; ABO-incompatible transplantation; AR; acute rejection; DSA; donor-specific antibody; eGFR; estimated glomerular filtration rate; IgAN; IgA nephropathy; KTx; kidney transplantation; MP; methylprednisolone; MMF; mycophenolate mofetil; rit; rituximab;
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; donor-specific antibody; human leukocyte antigen; lung transplant; bronchiolitis obliterans syndrome; death;
Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?
Keywords: آنتی بادی اختصاصی اهداکننده; SAB; Single antigen bead array; AMR; Antibody-mediated rejection; CDC; Complement-dependent cytotoxic; DSA; Donor-specific antibodies; IQR; Interquartilic range; MFI; Mean fluorescence index; Antibody-mediated rejection; Complement; Donor-specific antibod
Detection of antibodies in eluates of immunoadsorption causing humoural rejection in patients after solid organ transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; Donor-specific antibody; HLA-antibody; Non-HLA-antibody; Antibody-mediated rejection; Immunoadsorption; Graft survival; Eluat
Pediatric Heart Transplantation for Congenital and Restrictive Cardiomyopathy
Keywords: آنتی بادی اختصاصی اهداکننده; ABOi; ABO incompatible; AMR; Antibody-mediated rejection; CDC; Complement-dependent cytotoxicity; CHD; congenital heart disease; CPB; cardiopulmonary bypass; CRF; calculated reaction frequency; DCM; dilatated cardiomyopathy; DSA; donor-specific antibody;
Morphologic aspects of antibody-mediated rejection in renal allografts
Keywords: آنتی بادی اختصاصی اهداکننده; antibody-mediated rejection; C4d; donor-specific antibody; transplant glomerulitis; peritubular capillaritis
Successful lung transplantation in the presence of pre-existing donor-specific cytotoxic HLA Class II antibodies
Keywords: آنتی بادی اختصاصی اهداکننده; lung transplantation; HLA antibody; donor-specific antibody; rejection; LSA;
Immune Monitoring of Kidney Allografts
Keywords: آنتی بادی اختصاصی اهداکننده; Biomarker; rejection; kidney transplant; donor-specific antibody; chemokines;
Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection
Keywords: آنتی بادی اختصاصی اهداکننده; chronic rejection; donor-specific antibody; flow crossmatching; post-transplant antibody monitoring;
Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; HLA antibody; Donor-specific antibody; HLA-DRB; Renal transplantation; Chronic antibody-mediated rejection
Emerging role of donor-specific anti–human leukocyte antigen antibody determination for clinical management after solid organ transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; HLA antibody; Antibody-mediated rejection; C4d; Donor-specific antibody; Solid organ transplantation
Factors Associated With and Predictive of Persistence of Donor-Specific Antibody After Treatment With Plasmapheresis and Intravenous Immunoglobulin
Keywords: آنتی بادی اختصاصی اهداکننده; desensitization; plasmapheresis; IVIg; donor-specific antibody;
Desensitization protocols improving access and outcome in transplantation
Keywords: آنتی بادی اختصاصی اهداکننده; ABO incompatible transplantation; Desensitization; Double filtration plasmapheresis; HLA-specific antibody; Intravenous immunoglobulin (IVIg); Plasmapheresis; Sensitization; Transplantation; ABO-DSA; antibody to donor ABO antigens; ABOi; ABO incompatible;